Literature DB >> 22479887

Intravenous use of illicit buprenorphine/naloxone to reverse an acute heroin overdose.

Michael A Yokell1, Nickolas D Zaller, Traci C Green, Michelle McKenzie, Josiah D Rich.   

Abstract

A case of heroin overdose reversed through the intravenous (IV) administration of a crushed sublingual tablet of buprenorphine/naloxone (Suboxone) by a lay responder is described. Although the sublingual administration of buprenorphine/naloxone to reverse an overdose has been reported elsewhere, this is the first report of IV administration. Healthcare professionals should be aware that injection drug users may respond to an opioid overdose by injecting buprenorphine/naloxone and should consequently counsel all opioid-using patients on the proper response to an overdose. Physicians should also consider prescribing naloxone to at-risk patients. The work of community-based naloxone distribution programs should be expanded.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22479887      PMCID: PMC3343634          DOI: 10.5055/jom.2012.0098

Source DB:  PubMed          Journal:  J Opioid Manag        ISSN: 1551-7489


  17 in total

Review 1.  Clinical and pharmacological evaluation of buprenorphine and naloxone combinations: why the 4:1 ratio for treatment?

Authors:  John Mendelson; Reese T Jones
Journal:  Drug Alcohol Depend       Date:  2003-05-21       Impact factor: 4.492

Review 2.  Heroin overdose: causes and consequences.

Authors:  M Warner-Smith; S Darke; M Lynskey; W Hall
Journal:  Addiction       Date:  2001-08       Impact factor: 6.526

3.  Prescribing naloxone to actively injecting heroin users: a program to reduce heroin overdose deaths.

Authors:  Sarz Maxwell; Dan Bigg; Karen Stanczykiewicz; Suzanne Carlberg-Racich
Journal:  J Addict Dis       Date:  2006

4.  Evaluation of a naloxone distribution and administration program in New York City.

Authors:  Tinka Markham Piper; Sharon Stancliff; Sasha Rudenstine; Susan Sherman; Vijay Nandi; Allan Clear; Sandro Galea
Journal:  Subst Use Misuse       Date:  2008       Impact factor: 2.164

5.  Distinguishing signs of opioid overdose and indication for naloxone: an evaluation of six overdose training and naloxone distribution programs in the United States.

Authors:  Traci C Green; Robert Heimer; Lauretta E Grau
Journal:  Addiction       Date:  2008-04-16       Impact factor: 6.526

6.  Saved by the nose: bystander-administered intranasal naloxone hydrochloride for opioid overdose.

Authors:  Maya Doe-Simkins; Alexander Y Walley; Andy Epstein; Peter Moyer
Journal:  Am J Public Health       Date:  2009-05       Impact factor: 9.308

7.  Buprenorphine: dose-related blockade of opioid challenge effects in opioid dependent humans.

Authors:  W K Bickel; M L Stitzer; G E Bigelow; I A Liebson; D R Jasinski; R E Johnson
Journal:  J Pharmacol Exp Ther       Date:  1988-10       Impact factor: 4.030

8.  Attitudes about prescribing take-home naloxone to injection drug users for the management of heroin overdose: a survey of street-recruited injectors in the San Francisco Bay Area.

Authors:  Karen H Seal; Moher Downing; Alex H Kral; Shannon Singleton-Banks; Jon-Paul Hammond; Jennifer Lorvick; Dan Ciccarone; Brian R Edlin
Journal:  J Urban Health       Date:  2003-06       Impact factor: 3.671

9.  A case of heroin overdose reversed by sublingually administered buprenorphine/naloxone (Suboxone).

Authors:  Christopher Welsh; Susan G Sherman; Karin E Tobin
Journal:  Addiction       Date:  2008-07       Impact factor: 6.526

10.  Serious overdoses involving buprenorphine in Helsinki.

Authors:  J Boyd; T Randell; H Luurila; M Kuisma
Journal:  Acta Anaesthesiol Scand       Date:  2003-09       Impact factor: 2.105

View more
  4 in total

1.  Association between non-fatal opioid overdose and encounters with healthcare and criminal justice systems: Identifying opportunities for intervention.

Authors:  Karla D Wagner; Lin Liu; Peter J Davidson; Jazmine Cuevas-Mota; Richard F Armenta; Richard S Garfein
Journal:  Drug Alcohol Depend       Date:  2015-05-27       Impact factor: 4.492

2.  Withdrawal from Buprenorphine/Naloxone and Maintenance with a Natural Dopaminergic Agonist: A Cautionary Note.

Authors:  Kenneth Blum; Marlene Oscar-Berman; John Femino; Roger L Waite; Lisa Benya; John Giordano; Joan Borsten; William B Downs; Eric R Braverman; Raquel Loehmann; Kristina Dushaj; David Han; Thomas Simpatico; Mary Hauser; Debmalya Barh; Thomas McLaughlin
Journal:  J Addict Res Ther       Date:  2013-04-23

Review 3.  Treatment of opioid overdose: current approaches and recent advances.

Authors:  Stevie C Britch; Sharon L Walsh
Journal:  Psychopharmacology (Berl)       Date:  2022-04-07       Impact factor: 4.530

4.  Exposure to fentanyl-contaminated heroin and overdose risk among illicit opioid users in Rhode Island: A mixed methods study.

Authors:  Jennifer J Carroll; Brandon D L Marshall; Josiah D Rich; Traci C Green
Journal:  Int J Drug Policy       Date:  2017-06-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.